tiprankstipranks
Stryker Corporation (SYK)
NYSE:SYK
US Market
SYK
Stryker
RESEARCH TOOLSreports
Want to see SYK full AI Analyst Report?

Stryker (SYK) Stock Forecast & Price Target

2,662 Followers
See the Price Targets and Ratings of:

SYK Analyst Ratings

Strong Buy
23Ratings
Strong Buy
18 Buy
5 Hold
0 Sell
Based on 23 analysts giving stock ratings to
Stryker
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

SYK Stock 12 Month Forecast

Average Price Target

$391.67
▲(14.08% Upside)
Based on 23 Wall Street analysts offering 12 month price targets for Stryker in the last 3 months. The average price target is $391.67 with a high forecast of $465.00 and a low forecast of $315.00. The average price target represents a 14.08% change from the last price of $343.32.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"293":"$293","466":"$466","336.25":"$336.3","379.5":"$379.5","422.75":"$422.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":465,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$465.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":391.66666666666663,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$391.67</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":315,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$315.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[293,336.25,379.5,422.75,466],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2025","6":"Nov<br/>2025","9":"Feb<br/>2026","12":"May<br/>2026","25":"May<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,294.73,307.8276923076923,320.92538461538464,334.0230769230769,347.12076923076927,360.21846153846155,373.31615384615384,386.4138461538462,399.51153846153846,412.60923076923075,425.7069230769231,438.8046153846154,451.90230769230766,{"y":465,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,294.73,302.18666666666667,309.6433333333333,317.1,324.5566666666667,332.0133333333333,339.46999999999997,346.9266666666667,354.3833333333333,361.84,369.2966666666666,376.75333333333333,384.21,{"y":391.66666666666663,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,294.73,296.2892307692308,297.84846153846155,299.40769230769234,300.9669230769231,302.5261538461539,304.0853846153846,305.6446153846154,307.20384615384614,308.76307692307694,310.3223076923077,311.88153846153847,313.4407692307692,{"y":315,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":370.416,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":377.22,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":393.789,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":374.98,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":388.499,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":362.264,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":354.395,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":370.392,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 33,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":350.521,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 38,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":367.146,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":385.975,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 37,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":329.4,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":294.73,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 37,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$465.00Average Price Target$391.67Lowest Price Target$315.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Bank of America Securities Analyst forecast on SYK
Travis Steed
Bank of America Securities
Bank of America Securities
―
Buy
―
Reiterated
05/14/26
Analysts Offer Insights on Healthcare Companies: Stryker (NYSE: SYK) and US Physical Therapy (NYSE: USPH)
Truist Financial Analyst forecast on SYK
Richard Newitter
Truist Financial
Truist Financial
$380→$330
Hold
-3.88%
Downside
Reiterated
05/04/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Climb Bio (NASDAQ: CLYM), ICU Medical (NASDAQ: ICUI) and Stryker (NYSE: SYK)
William Blair Analyst forecast on SYK
Steven Lichtman
William Blair
William Blair
―
Buy
―
Reiterated
05/01/26
Analysts Conflicted on These Healthcare Names: Moderna (NASDAQ: MRNA) and Stryker (NYSE: SYK)
Robert W. Baird Analyst forecast on SYK
Jeff Johnson
Robert W. Baird
Robert W. Baird
$437→$385
Buy
12.14%
Upside
Reiterated
05/01/26
Stryker price target lowered to $385 from $437 at BairdStryker price target lowered to $385 from $437 at Baird
Deutsche Bank Analyst forecast on SYK
Pito Chickering
Deutsche Bank
Deutsche Bank
$402→$315
Hold
-8.25%
Downside
Reiterated
05/01/26
Stryker price target lowered to $315 from $402 at Deutsche BankStryker price target lowered to $315 from $402 at Deutsche Bank
J.P. Morgan Analyst forecast on SYK
Robbie Marcus
J.P. Morgan
J.P. Morgan
$445→$400
Buy
16.51%
Upside
Reiterated
05/01/26
J.P. Morgan Keeps Their Buy Rating on Stryker (SYK)
TD Cowen Analyst forecast on SYK
Mathew Blackman
TD Cowen
TD Cowen
$387→$355
Hold
3.40%
Upside
Reiterated
05/01/26
TD Cowen Keeps Their Hold Rating on Stryker (SYK)
Barclays Analyst forecast on SYK
Matt Miksic
Barclays
Barclays
$394
Buy
14.76%
Upside
Reiterated
05/01/26
Analysts Are Bullish on These Healthcare Stocks: BrightSpring Health Services, Inc. (BTSG), Stryker (SYK)
BTIG Analyst forecast on SYK
Ryan Zimmerman
BTIG
BTIG
$397→$379
Buy
10.39%
Upside
Reiterated
05/01/26
BTIG Reaffirms Their Buy Rating on Stryker (SYK)
Needham Analyst forecast on SYK
Michael Matson
Needham
Needham
$454→$418
Buy
21.75%
Upside
Reiterated
05/01/26
Needham Remains a Buy on Stryker (SYK)
Evercore ISI Analyst forecast on SYK
Vijay Kumar
Evercore ISI
Evercore ISI
$365→$355
Buy
3.40%
Upside
Reiterated
05/01/26
Stryker price target lowered to $355 from $365 at Evercore ISIStryker price target lowered to $355 from $365 at Evercore ISI
Canaccord Genuity Analyst forecast on SYK
William Plovanic
Canaccord Genuity
Canaccord Genuity
$435→$400
Buy
16.51%
Upside
Reiterated
05/01/26
Stryker price target lowered to $400 from $435 at CanaccordStryker price target lowered to $400 from $435 at Canaccord
Wells Fargo Analyst forecast on SYK
Larry Biegelsen
Wells Fargo
Wells Fargo
$456→$418
Buy
21.75%
Upside
Reiterated
05/01/26
Analysts Offer Insights on Healthcare Companies: Stryker (NYSE: SYK) and Larimar Therapeutics (NASDAQ: LRMR)
Bernstein Analyst forecast on SYK
Lee Hambright
Bernstein
Bernstein
$465→$410
Buy
19.42%
Upside
Reiterated
05/01/26
Bernstein Reaffirms Their Buy Rating on Stryker (SYK)
RBC Capital Analyst forecast on SYK
Shagun Singh Chadha
RBC Capital
RBC Capital
$435
Buy
26.70%
Upside
Reiterated
05/01/26
Analysts Offer Insights on Healthcare Companies: Janux Therapeutics Inc (NASDAQ: JANX), Stryker (NYSE: SYK) and CareDx (NASDAQ: CDNA)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Bank of America Securities Analyst forecast on SYK
Travis Steed
Bank of America Securities
Bank of America Securities
―
Buy
―
Reiterated
05/14/26
Analysts Offer Insights on Healthcare Companies: Stryker (NYSE: SYK) and US Physical Therapy (NYSE: USPH)
Truist Financial Analyst forecast on SYK
Richard Newitter
Truist Financial
Truist Financial
$380→$330
Hold
-3.88%
Downside
Reiterated
05/04/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Climb Bio (NASDAQ: CLYM), ICU Medical (NASDAQ: ICUI) and Stryker (NYSE: SYK)
William Blair Analyst forecast on SYK
Steven Lichtman
William Blair
William Blair
―
Buy
―
Reiterated
05/01/26
Analysts Conflicted on These Healthcare Names: Moderna (NASDAQ: MRNA) and Stryker (NYSE: SYK)
Robert W. Baird Analyst forecast on SYK
Jeff Johnson
Robert W. Baird
Robert W. Baird
$437→$385
Buy
12.14%
Upside
Reiterated
05/01/26
Stryker price target lowered to $385 from $437 at BairdStryker price target lowered to $385 from $437 at Baird
Deutsche Bank Analyst forecast on SYK
Pito Chickering
Deutsche Bank
Deutsche Bank
$402→$315
Hold
-8.25%
Downside
Reiterated
05/01/26
Stryker price target lowered to $315 from $402 at Deutsche BankStryker price target lowered to $315 from $402 at Deutsche Bank
J.P. Morgan Analyst forecast on SYK
Robbie Marcus
J.P. Morgan
J.P. Morgan
$445→$400
Buy
16.51%
Upside
Reiterated
05/01/26
J.P. Morgan Keeps Their Buy Rating on Stryker (SYK)
TD Cowen Analyst forecast on SYK
Mathew Blackman
TD Cowen
TD Cowen
$387→$355
Hold
3.40%
Upside
Reiterated
05/01/26
TD Cowen Keeps Their Hold Rating on Stryker (SYK)
Barclays Analyst forecast on SYK
Matt Miksic
Barclays
Barclays
$394
Buy
14.76%
Upside
Reiterated
05/01/26
Analysts Are Bullish on These Healthcare Stocks: BrightSpring Health Services, Inc. (BTSG), Stryker (SYK)
BTIG Analyst forecast on SYK
Ryan Zimmerman
BTIG
BTIG
$397→$379
Buy
10.39%
Upside
Reiterated
05/01/26
BTIG Reaffirms Their Buy Rating on Stryker (SYK)
Needham Analyst forecast on SYK
Michael Matson
Needham
Needham
$454→$418
Buy
21.75%
Upside
Reiterated
05/01/26
Needham Remains a Buy on Stryker (SYK)
Evercore ISI Analyst forecast on SYK
Vijay Kumar
Evercore ISI
Evercore ISI
$365→$355
Buy
3.40%
Upside
Reiterated
05/01/26
Stryker price target lowered to $355 from $365 at Evercore ISIStryker price target lowered to $355 from $365 at Evercore ISI
Canaccord Genuity Analyst forecast on SYK
William Plovanic
Canaccord Genuity
Canaccord Genuity
$435→$400
Buy
16.51%
Upside
Reiterated
05/01/26
Stryker price target lowered to $400 from $435 at CanaccordStryker price target lowered to $400 from $435 at Canaccord
Wells Fargo Analyst forecast on SYK
Larry Biegelsen
Wells Fargo
Wells Fargo
$456→$418
Buy
21.75%
Upside
Reiterated
05/01/26
Analysts Offer Insights on Healthcare Companies: Stryker (NYSE: SYK) and Larimar Therapeutics (NASDAQ: LRMR)
Bernstein Analyst forecast on SYK
Lee Hambright
Bernstein
Bernstein
$465→$410
Buy
19.42%
Upside
Reiterated
05/01/26
Bernstein Reaffirms Their Buy Rating on Stryker (SYK)
RBC Capital Analyst forecast on SYK
Shagun Singh Chadha
RBC Capital
RBC Capital
$435
Buy
26.70%
Upside
Reiterated
05/01/26
Analysts Offer Insights on Healthcare Companies: Janux Therapeutics Inc (NASDAQ: JANX), Stryker (NYSE: SYK) and CareDx (NASDAQ: CDNA)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxx
xxx
xxx
xxx
xxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Stryker

3 Months
xxx
Success Rate
13/17 ratings generated profit
76%
Average Return
+3.81%
Copying xxxxxxxxxxxxxxxxxx
 trades and holding each position for 3 Months would result in 76.47% of your transactions generating a profit, with an average return of +3.81% per trade.
1 Year
Larry BiegelsenWells Fargo
Success Rate
18/25 ratings generated profit
72%
Average Return
+9.04%
Copying Larry Biegelsen's trades and holding each position for 1 Year would result in 72.00% of your transactions generating a profit, with an average return of +9.04% per trade.
2 Years
xxx
Success Rate
23/30 ratings generated profit
77%
Average Return
+16.31%
Copying xxxxxxxxxxxxxxxxxx
 trades and holding each position for 2 Years would result in 76.67% of your transactions generating a profit, with an average return of +16.31% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

SYK Analyst Recommendation Trends

Rating
Jan 26
Feb 26
Mar 26
Apr 26
May 26
Strong Buy
0
0
0
0
1
Buy
38
28
37
26
36
Hold
9
7
7
5
8
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
47
35
44
31
45
In the current month, SYK has received 37 Buy Ratings, 8 Hold Ratings, and 0 Sell Ratings. SYK average Analyst price target in the past 3 months is 391.67.
Each month's total comprises the sum of three months' worth of ratings.

SYK Financial Forecast

SYK Earnings Forecast

Next quarter’s earnings estimate for SYK is $3.48 with a range of $3.24 to $3.61. The previous quarter’s EPS was $2.60. SYK beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year SYK has Performed in-line its overall industry.
Next quarter’s earnings estimate for SYK is $3.48 with a range of $3.24 to $3.61. The previous quarter’s EPS was $2.60. SYK beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year SYK has Performed in-line its overall industry.

SYK Sales Forecast

Next quarter’s sales forecast for SYK is $6.58B with a range of $6.52B to $6.80B. The previous quarter’s sales results were $6.02B. SYK beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year SYK has Performed in-line its overall industry.
Next quarter’s sales forecast for SYK is $6.58B with a range of $6.52B to $6.80B. The previous quarter’s sales results were $6.02B. SYK beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year SYK has Performed in-line its overall industry.

SYK Stock Forecast FAQ

What is SYK’s average 12-month price target, according to analysts?
Based on analyst ratings, Stryker Corporation’s 12-month average price target is 391.67.
    What is SYK’s upside potential, based on the analysts’ average price target?
    Stryker Corporation has 14.08% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is SYK a Buy, Sell or Hold?
          Stryker Corporation has a consensus rating of Strong Buy which is based on 18 buy ratings, 5 hold ratings and 0 sell ratings.
            What is Stryker Corporation’s price target?
            The average price target for Stryker Corporation is 391.67. This is based on 23 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $465.00 ,the lowest forecast is $315.00. The average price target represents 14.08% Increase from the current price of $343.32.
              What do analysts say about Stryker Corporation?
              Stryker Corporation’s analyst rating consensus is a Strong Buy. This is based on the ratings of 23 Wall Streets Analysts.
                How can I buy shares of SYK?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.